The Rudolf Buchheim Award, endowed with EUR 1,500, is presented by the German Society for Experimental and Clinical Pharmacology and Toxicology and is considered one of the most prestigious awards for early-career scientists in this field. It recognizes outstanding scientific publications in experimental and clinical pharmacology and toxicology, with a particular emphasis on innovative approaches and methodological excellence.

The award highlights the high scientific quality of Dr. Voss’s work and its relevance to biomedical research. At the same time, it underscores the importance of modern single-cell analyses for understanding complex disease processes.

We warmly congratulate Carola Voss on this achievement and wish her and her research group continued success in their future research endeavors.

Original publication

Voss C, Han L, Ansari M, Strunz M, Haefner V, Angelidis I, Mayr CH, Berthing T, Zhou Q, Guenther EM, Huzain O, Schmid O, Vogel U, Gote-Schniering J, Gaedcke S, Theis FJ, Schiller HB, Stoeger T. Toward a ToxAtlas of Carbon-Based Nanomaterials: Single-Cell RNA Sequencing Reveals Initiating Cell Circuits in Pulmonary Inflammation. ACS Nano. 2025 Nov 18;19(45):39139-39156. doi: 10.1021/acsnano.5c12054. Epub 2025 Nov 3. PMID: 41183169; PMCID: PMC12632174.

Award publication

Voss C. Rudolf Buchheim Award 2026: Toward a ToxAtlas of carbon-based nanomaterials: single-cell RNA sequencing reveals initiating cell circuits in pulmonary inflammation. Naunyn Schmiedebergs Arch Pharmacol. 2026 Mar 18. doi: 10.1007/s00210-026-05170-7. Epub ahead of print. PMID: 41848856.